Literature DB >> 22387017

Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.

Jong-Min Lee1, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Eliana Marisa Ramos, Richard H Myers, Michael R Hayden, Patrick J Morrison, Martha Nance, Christopher A Ross, Russell L Margolis, Ferdinando Squitieri, Annamaria Griguoli, Stefano Di Donato, Estrella Gomez-Tortosa, Carmen Ayuso, Oksana Suchowersky, Ronald J Trent, Elizabeth McCusker, Andrea Novelletto, Marina Frontali, Randi Jones, Tetsuo Ashizawa, Samuel Frank, Marie-Helene Saint-Hilaire, Steven M Hersch, Herminia D Rosas, Diane Lucente, Madaline B Harrison, Andrea Zanko, Ruth K Abramson, Karen Marder, Jorge Sequeiros, Marcy E MacDonald, James F Gusella.   

Abstract

Age at the onset of motor symptoms in Huntington disease (HD) is determined largely by the length of a CAG repeat expansion in HTT but is also influenced by other genetic factors. We tested whether common genetic variation near the mutation site is associated with differences in the distribution of expanded CAG alleles or age at the onset of motor symptoms. To define disease-associated single-nucleotide polymorphisms (SNPs), we compared 4p16.3 SNPs in HD subjects with population controls in a case:control strategy, which revealed that the strongest signals occurred at a great distance from the HD mutation as a result of "synthetic association" with SNP alleles that are of low frequency in population controls. Detailed analysis delineated a prominent ancestral haplotype that accounted for ∼50% of HD chromosomes and extended to at least 938 kb on about half of these. Together, the seven most abundant haplotypes accounted for ∼83% of HD chromosomes. Neither the extended shared haplotype nor the individual local HTT haplotypes were associated with altered CAG-repeat length distribution or residual age at the onset of motor symptoms, arguing against modification of these disease features by common cis-regulatory elements. Similarly, the 11 most frequent control haplotypes showed no trans-modifier effect on age at the onset of motor symptoms. Our results argue against common local regulatory variation as a factor influencing HD pathogenesis, suggesting that genetic modifiers be sought elsewhere in the genome. They also indicate that genome-wide association analysis with a small number of cases can be effective for regional localization of genetic defects, even when a founder effect accounts for only a fraction of the disorder. Copyright Â
© 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22387017      PMCID: PMC3309179          DOI: 10.1016/j.ajhg.2012.01.005

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Recombination events suggest potential sites for the Huntington's disease gene.

Authors:  M E MacDonald; J L Haines; M Zimmer; S V Cheng; S Youngman; W L Whaley; N Wexler; M Bucan; B A Allitto; B Smith
Journal:  Neuron       Date:  1989-08       Impact factor: 17.173

2.  Complex patterns of linkage disequilibrium in the Huntington disease region.

Authors:  M E MacDonald; C Lin; L Srinidhi; G Bates; M Altherr; W L Whaley; H Lehrach; J Wasmuth; J F Gusella
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

3.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

5.  HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.

Authors:  Simon C Warby; Henk Visscher; Jennifer A Collins; Crystal N Doty; Catherine Carter; Stefanie L Butland; Anna R Hayden; Ichiro Kanazawa; Colin J Ross; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

6.  The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD.

Authors:  L A Farrer; L A Cupples; P Wiater; P M Conneally; J F Gusella; R H Myers
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

7.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

Review 8.  The Huntington's disease candidate region exhibits many different haplotypes.

Authors:  M E MacDonald; A Novelletto; C Lin; D Tagle; G Barnes; G Bates; S Taylor; B Allitto; M Altherr; R Myers
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

9.  Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.

Authors:  Luc Djoussé; Beth Knowlton; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Christopher A Ross; Russel L Margolis; Adam Rosenblatt; Alexandra Durr; Catherine Dode; Patrick J Morrison; Andrea Novelletto; Marina Frontali; Ronald J A Trent; Elizabeth McCusker; Estrella Gómez-Tortosa; David Mayo Cabrero; Randi Jones; Andrea Zanko; Martha Nance; Ruth K Abramson; Oksana Suchowersky; Jane S Paulsen; Madaline B Harrison; Qiong Yang; L Adrienne Cupples; Jayalakshmi Mysore; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Neurogenetics       Date:  2004-03-17       Impact factor: 2.660

10.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Authors:  J-M Lee; E M Ramos; J-H Lee; T Gillis; J S Mysore; M R Hayden; S C Warby; P Morrison; M Nance; C A Ross; R L Margolis; F Squitieri; S Orobello; S Di Donato; E Gomez-Tortosa; C Ayuso; O Suchowersky; R J A Trent; E McCusker; A Novelletto; M Frontali; R Jones; T Ashizawa; S Frank; M H Saint-Hilaire; S M Hersch; H D Rosas; D Lucente; M B Harrison; A Zanko; R K Abramson; K Marder; J Sequeiros; J S Paulsen; G B Landwehrmeyer; R H Myers; M E MacDonald; J F Gusella
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

View more
  31 in total

1.  2016 William Allan Award: Human Disease Research: Genetic Cycling and Re-cycling.

Authors:  James F Gusella
Journal:  Am J Hum Genet       Date:  2017-03-02       Impact factor: 11.025

2.  A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.

Authors:  Chris Kay; Jennifer A Collins; Nicholas S Caron; Luciana de Andrade Agostinho; Hailey Findlay-Black; Lorenzo Casal; Dulika Sumathipala; Vajira H W Dissanayake; Mario Cornejo-Olivas; Fiona Baine; Amanda Krause; Jacquie L Greenberg; Carmen Lúcia Antão Paiva; Ferdinando Squitieri; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2019-11-07       Impact factor: 11.025

3.  Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.

Authors:  Ana María Estrada-Sánchez; George V Rebec
Journal:  Basal Ganglia       Date:  2012-07-01

4.  Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.

Authors:  Kyung-Hee Kim; Kawther Abu Elneel; Jun Wan Shin; Jae Whan Keum; David Seong; Seung Kwak; Ramee Lee; James F Gusella; Marcy E MacDonald; Ihn Sik Seong; Jong-Min Lee
Journal:  J Hum Genet       Date:  2019-07-11       Impact factor: 3.172

5.  Haplotype-based stratification of Huntington's disease.

Authors:  Michael J Chao; Tammy Gillis; Ranjit S Atwal; Jayalakshmi Srinidhi Mysore; Jamshid Arjomand; Denise Harold; Peter Holmans; Lesley Jones; Michael Orth; Richard H Myers; Seung Kwak; Vanessa C Wheeler; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Eur J Hum Genet       Date:  2017-08-23       Impact factor: 4.246

6.  A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.

Authors:  Miguel Alves-Ferreira; Teresa Coelho; Diana Santos; Jorge Sequeiros; Isabel Alonso; Alda Sousa; Carolina Lemos
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

7.  Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.

Authors:  Aram Shin; Baehyun Shin; Jun Wan Shin; Kyung-Hee Kim; Ranjit S Atwal; Jennifer M Hope; Tammy Gillis; John D Leszyk; Scott A Shaffer; Ramee Lee; Seung Kwak; Marcy E MacDonald; James F Gusella; Ihn Sik Seong; Jong-Min Lee
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

8.  Sequence-Level Analysis of the Major European Huntington Disease Haplotype.

Authors:  Jong-Min Lee; Kyung-Hee Kim; Aram Shin; Michael J Chao; Kawther Abu Elneel; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Julia A Kaye; Hengameh Zahed; Ian H Kratter; Aaron C Daub; Steven Finkbeiner; Hong Li; Jared C Roach; Nathan Goodman; Leroy Hood; Richard H Myers; Marcy E MacDonald; James F Gusella
Journal:  Am J Hum Genet       Date:  2015-08-27       Impact factor: 11.025

9.  In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides.

Authors:  Amber L Southwell; Niels H Skotte; Holly B Kordasiewicz; Michael E Østergaard; Andrew T Watt; Jeffrey B Carroll; Crystal N Doty; Erika B Villanueva; Eugenia Petoukhov; Kuljeet Vaid; Yuanyun Xie; Susan M Freier; Eric E Swayze; Punit P Seth; Clarence Frank Bennett; Michael R Hayden
Journal:  Mol Ther       Date:  2014-08-07       Impact factor: 11.454

10.  Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.

Authors: 
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.